- Glidden, David;
- Grant, Robert;
- Marcus, JL;
- Glidden, DV;
- McMahan, V;
- Lama, JR;
- Mayer, KH;
- Liu, AY;
- Montoya-Herrera, O;
- Casapia, M;
- Hoagland, B;
- Grant, RM
Background: In addition to protecting against HIV acquisition, antiretroviral preexposure prophylaxis (PrEP) using topical 1% tenofovir gel reduced Herpes simplex virus type 2 (HSV-2) acquisition by 51% among women in the CAPRISA 004 study. We examined the
